author-photo

Martin Shea

Baylor College of Medicine

33

Papers

1615

Citations

Citation Trend

Filter By

Papers (22) Sort By

Journal Conference Others

A novel role of ADGRF1 (GPR110) in promoting cellular quiescence and chemoresistance in human epidermal growth factor receptor 2-positive breast cancer.

2021 The FASEB Journal
Show All
- Source
- Cite
- Save
Citations (3)
Neratinib plus trastuzumab is superior to pertuzumab plus trastuzumab in HER2-positive breast cancer xenograft models

2021
Show All
- Source
- Cite
- Save
Citations (0)
Abstract 1077: Acquired neratinib resistance is associated with acquisition of HER2 and PIK3CA mutations and can be overcome using potent drug combinations in HER2-positive breast cancer models

2021 Cancer Research
Show All
- Source
- Cite
- Save
Citations (0)
Abstract PD8-03: A FOXA1/FRA1-centered transcriptional axis regulates interferon signaling in high FOXA1-associated endocrine-resistant and metastatic breast cancer

2021 Cancer Research
Show All
- Source
- Cite
- Save
Citations (0)
Abstract 1911: HER2 L755S mutation is associated with acquired resistance to lapatinib and neratinib, and confers cross-resistance to tucatinib in HER2-positive breast cancer models

2020 Cancer Research
Show All
- Source
- Cite
- Save
Citations (2)
Abstract P6-04-02: Integrative cistromic/transcriptomic profiling identifies a high FOXA1/ER-activated pro-metastatic secretome in endocrine-resistant breast cancer

2020 Cancer Research
Show All
- Source
- Cite
- Save
Citations (0)
Abstract 4757: Targeting the mevalonate pathway in HER2+breast cancer to overcome resistance and enhance anti-HER2 therapy efficacy

2019 Cancer Research
Show All
- Source
- Cite
- Save
Citations (0)
In vivo Longitudinal Imaging of RNAi Induced Endocrine Therapy Resistance in Breast Cancer

2019 Journal of Biophotonics
Show All
- Source
- Cite
- Save
Citations (1)
HER2 Reactivation through Acquisition of the HER2 L755S Mutation as a Mechanism of Acquired Resistance to HER2-targeted Therapy in HER2+ Breast Cancer

2017 Clinical Cancer Research
Show All
- Source
- Cite
- Save
Citations (59)
FOXA1 overexpression mediates endocrine resistance by altering the ER transcriptome and IL-8 expression in ER-positive breast cancer

2016 Proceedings of the National Academy of Sciences of the United States of America
Show All
- Source
- Cite
- Save
Citations (83)